Effect of Apple Polyphenols on Vascular Oxidative Stress and Endothelium Function Study (APP trial_2016)
A Double-blind, Placebo-controlled, Randomized Clinical Trial on the Metabolic and Vascular Effects of a Dietary Supplementation With Apple Polyphenols in Overweight Subjects
1 other identifier
interventional
62
1 country
1
Brief Summary
Apple polyphenols are mostly acknowledged for their hypoglycaemic properties, but represent an apple active fraction with many pharmacological functions. The study aim was to examine their effect on uricemia and endothelial function in a sample of overweight subjects. This was a two-phases study. The in vitro experiment aimed to evaluate the apple polyphenols' ability to lower uric acid in comparison with allopurinol. The in vivo study consisted in a randomized, double-blind, parallel placebo-controlled clinical trial involving 62 overweight volunteers with suboptimal values of fasting plasma glucose (100 mg/dL≤FPG≤125 mg/dL), randomized to be treated with 300 mg apple polyphenols or placebo for 8 weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2016
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2016
CompletedFirst Submitted
Initial submission to the registry
February 7, 2017
CompletedFirst Posted
Study publicly available on registry
February 15, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2017
CompletedFebruary 1, 2024
January 1, 2024
9 months
February 7, 2017
January 30, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Endothelial function
Change in arterial diameter after ischemic stimulus
8 week
Study Arms (2)
Apple polyphenols
ACTIVE COMPARATORWhite capsule containing 300 mg of apple extract (Malus Domestica) with glycosilated polyphenols (≥90%) including glycosilated phloritzin (15-30%), chlorogenic acid (10-25%) and quercetin (15-25%)
Placebo
PLACEBO COMPARATORIndistinguishable capsules with similar dimension, colour, odour and taste
Interventions
Eligibility Criteria
You may qualify if:
- Body mass index (BMI)\>25 kg/m2
- Fasting plasma glucose 100 mg/dL ≤ FPG ≤ 125 mg/dL
You may not qualify if:
- Patients with obesity (body mass index \[BMI\] \<30 Kg/m2)
- diabetes mellitus
- personal history of atherosclerosis-related cardiovascular diseases (coronary artery disease
- cerebrovascular disease
- ultrasound diagnosed carotid atherosclerosis)
- absorption disease
- myopathy
- renal failure or chronic liver disease
- serious or invalidating other diseases reducing the subjects' ability to comply with the full protocol were excluded from the study as well as subjects with a known apple intolerance.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
S. Orsola-Malpighi University Hospital
Bologna, 40038, Italy
Related Publications (1)
Cicero AFG, Caliceti C, Fogacci F, Giovannini M, Calabria D, Colletti A, Veronesi M, Roda A, Borghi C. Effect of apple polyphenols on vascular oxidative stress and endothelium function: a translational study. Mol Nutr Food Res. 2017 Nov;61(11). doi: 10.1002/mnfr.201700373. Epub 2017 Sep 1.
PMID: 28755406RESULT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Full Professor of Internal Medicine
Study Record Dates
First Submitted
February 7, 2017
First Posted
February 15, 2017
Study Start
September 1, 2016
Primary Completion
June 1, 2017
Study Completion
June 1, 2017
Last Updated
February 1, 2024
Record last verified: 2024-01